Marko Radačić

427 total citations
28 papers, 356 citations indexed

About

Marko Radačić is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Marko Radačić has authored 28 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Marko Radačić's work include Biochemical and Molecular Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Synthesis and biological activity (3 papers). Marko Radačić is often cited by papers focused on Biochemical and Molecular Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Synthesis and biological activity (3 papers). Marko Radačić collaborates with scholars based in Croatia, Denmark and United Kingdom. Marko Radačić's co-authors include Ranko Stojković, Milivoj Boranić, Jens Overgaard, Margaret Fox, Marija Poljak‐Blaži, Cai Grau, Višnja Šverko, Berislav Bošnjak, Tihomir Balog and Maša Katić and has published in prestigious journals such as Food and Chemical Toxicology, Toxicology and Biomedicine & Pharmacotherapy.

In The Last Decade

Marko Radačić

27 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marko Radačić Croatia 10 94 45 45 40 39 28 356
Makiko Yamaguchi Japan 12 116 1.2× 30 0.7× 21 0.5× 29 0.7× 30 0.8× 35 559
Janice A. Lumpkin United States 11 241 2.6× 22 0.5× 44 1.0× 28 0.7× 51 1.3× 15 518
Karl A. Traul United States 11 126 1.3× 100 2.2× 42 0.9× 28 0.7× 23 0.6× 28 568
Siniša Ivanković Croatia 13 133 1.4× 16 0.4× 59 1.3× 27 0.7× 37 0.9× 41 408
Monica Carletti Italy 13 132 1.4× 43 1.0× 25 0.6× 71 1.8× 23 0.6× 29 582
Adèle Martial France 6 210 2.2× 33 0.7× 32 0.7× 8 0.2× 65 1.7× 8 444
Haeng Soon Park South Korea 8 118 1.3× 32 0.7× 40 0.9× 19 0.5× 9 0.2× 15 335
M. J. Fahrenbach China 13 135 1.4× 33 0.7× 28 0.6× 35 0.9× 36 0.9× 20 516
Livia Malorni Italy 14 176 1.9× 35 0.8× 131 2.9× 13 0.3× 73 1.9× 39 566
Neil A. Littlefield United States 11 73 0.8× 19 0.4× 70 1.6× 8 0.2× 18 0.5× 19 363

Countries citing papers authored by Marko Radačić

Since Specialization
Citations

This map shows the geographic impact of Marko Radačić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Radačić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Radačić more than expected).

Fields of papers citing papers by Marko Radačić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Radačić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Radačić. The network helps show where Marko Radačić may publish in the future.

Co-authorship network of co-authors of Marko Radačić

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Radačić. A scholar is included among the top collaborators of Marko Radačić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Radačić. Marko Radačić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stojković, Ranko, Grace Karminski‐Zamola, Livio Racanè, et al.. (2006). Antitumour efficiency of novel fluoro substituted6-amino-2-phenylbenzothiazole hydrochloride salts in vitro and invivo. Methods and Findings in Experimental and Clinical Pharmacology. 28(6). 347–347. 4 indexed citations
2.
Stojković, Ranko, et al.. (2005). Antitumor activity of novel N-sulfonylpyrimidine derivatives on the growth of anaplastic mammary carcinoma in vivo. Journal of Cancer Research and Clinical Oncology. 131(12). 829–836. 13 indexed citations
3.
Glavaš‐Obrovac, Ljubica, et al.. (2005). SYNTHESIS AND ANTITUMOR ACTIVITY OF 5-BROMO-1-MESYLURACIL. Nucleosides Nucleotides & Nucleic Acids. 24(5-7). 557–569. 11 indexed citations
4.
Stojković, Ranko & Marko Radačić. (2002). Cell killing of melanoma B16 in vivo by hyperthermia and cytotoxins. International Journal of Hyperthermia. 18(1). 62–71. 8 indexed citations
5.
Martin‐Kleiner, Irena, Zlata Flegar-Meštrić, Davorka Breljak, et al.. (2001). The effect of the zeolite clinoptilolite on serum chemistry and hematopoiesis in mice. Food and Chemical Toxicology. 39(7). 717–727. 74 indexed citations
6.
Pavelić, Krešimir, Maša Katić, Višnja Šverko, et al.. (2001). Immunostimulatory effect of natural clinoptilolite as a possible mechanism of its antimetastatic ability. Journal of Cancer Research and Clinical Oncology. 128(1). 37–44. 91 indexed citations
7.
Šverko, Višnja, et al.. (1999). Effect of cisplatin and 6-bromo-6-deoxy-l-ascorbic acid on some biochemical and functional parameters in mice. Toxicology. 137(1). 23–34. 2 indexed citations
8.
Šverko, Višnja, et al.. (1993). Lipid Bound Sialic Acid Concentration in Mice with Myeloid Leukemia and Alloxan Diabetes. Hormone and Metabolic Research. 25(8). 446–448. 2 indexed citations
9.
Radačić, Marko, et al.. (1993). Reduction of Cisplatinum-Induced Renal Toxicity in Mice by Tetrahydroindazolone Carboxylic Acid (HIDA). Acta Oncologica. 32(1). 53–56. 1 indexed citations
10.
Lindegaard, Jacob Christian, Marko Radačić, Azza A. Khalil, Michael R. Horsman, & Jens Overgaard. (1992). Cisplatin and Hyperthermia Treatment of A C3H Mammary Carcinoma in Vivo: Importance of sequence, interval, drug dose, and temperature. Acta Oncologica. 31(3). 347–351. 14 indexed citations
11.
Overgaard, Jens, Marko Radačić, & Cai Grau. (1991). Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.. PubMed. 51(2). 707–11. 30 indexed citations
12.
Peričić, Danka, Marija Poljak‐Blaži, Hari Manev, et al.. (1990). Immune response of stressed rats treated with drugs affecting serotoninergic and adrenergic transmission. Biomedicine & Pharmacotherapy. 44(7). 381–387. 6 indexed citations
13.
Gabrilovac, Jelka, Marko Radačić, Maja Osmak, & Milivoj Boranić. (1990). Opposing influence of age on the growth and colony-forming ability of mouse melanoma B16 and mammary adenocarcinoma: Correlation with natural killer activity. Cancer Immunology Immunotherapy. 32(1). 45–50. 8 indexed citations
14.
Radačić, Marko, et al.. (1987). Reduction of <i>cis</i>-Dichlorodiammineplatinum(II) Caused Nephrotoxicity by Indazolone Carboxilic Acid. Oncology. 44(1). 34–37. 1 indexed citations
15.
Orešković, Darko, et al.. (1986). Plasma level of dipropylacetamide and dipropylacetic acid and effect of these drugs on 5-hydroxytryptamine metabolism in mouse brain.. PubMed. 40(5). 191–3. 1 indexed citations
16.
Radačić, Marko, et al.. (1983). TOXICITY AND PHARMACOKINETIC STUDIES WITH CB3717. UCL Discovery (University College London). 1 indexed citations
17.
Fox, Marye Anne & Marko Radačić. (1982). Variations in chromosome numbers and their possible relationship to the development of 8-azaguanine resistance in V79 Chinese hamster cells. Cell Biology International Reports. 6(1). 39–48. 2 indexed citations
18.
Boranić, Milivoj & Marko Radačić. (1978). Distribution of 51Cr labeled leukemia cells in mice: comparison with representative normal cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(1). 122–7. 1 indexed citations
19.
Fox, Margaret & Marko Radačić. (1978). Adaptational origin of some purine-analogue resistant phenotypes in cultured mammalian cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 49(2). 275–296. 27 indexed citations
20.
Boranić, Milivoj, Marko Radačić, & Jelka Gabrilovac. (1974). Distribution and spread of 51Cr-labeled leukemia cells in mice.. PubMed. 2(2). 51–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makiko Yamaguchi Breakdown of academic impact, for papers by Janice A. Lumpkin Breakdown of academic impact, for papers by Karl A. Traul Breakdown of academic impact, for papers by Siniša Ivanković Breakdown of academic impact, for papers by Monica Carletti Breakdown of academic impact, for papers by Adèle Martial Breakdown of academic impact, for papers by Haeng Soon Park Breakdown of academic impact, for papers by M. J. Fahrenbach Breakdown of academic impact, for papers by Livia Malorni Breakdown of academic impact, for papers by Neil A. Littlefield
Rankless by CCL
2026